CPSC campaign 13114
Hazard
These child-resistant caps can fail to function properly and enable the cap to be removed by a child with the tamper-evident seal in place, posing a risk of unintentional ingestion and poisoning. These products contain acetaminophen and diphenhydramine which are required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
Remedy
Consumers should immediately stop using the recalled product and contact Novartis for instructions on how to return the product for a full refund.
The text above is quoted verbatim from the CPSC record. Confirm the affected units and the remedy with the manufacturer or CPSC. Recall data may be incomplete, delayed, or superseded.